{"id":8749,"date":"2013-11-18T00:58:05","date_gmt":"2013-11-18T05:58:05","guid":{"rendered":"http:\/\/goldstocksforex.com\/?p=8749"},"modified":"2013-11-18T00:58:05","modified_gmt":"2013-11-18T05:58:05","slug":"sp-500-and-nasdaq-bouyant","status":"publish","type":"post","link":"https:\/\/thepatientinvestor.com\/index.php\/2013\/11\/18\/sp-500-and-nasdaq-bouyant\/","title":{"rendered":"S&#038;P 500 and Nasdaq bouyant"},"content":{"rendered":"<p>The S&amp;P 500 is advancing strongly but expect some resistance at the target of 1800*. Penetration of the descending trendline on 13-week Twiggs Money Flow suggests that selling pressure is easing. Reversal below 1750 is unlikely at present, but would warn of a correction to at least the secondary trendline at 1700. Short corrections are indicative of long-term buying pressure.<\/p>\n<p><img data-recalc-dims=\"1\" loading=\"lazy\" decoding=\"async\" class=\"aligncenter\" width=\"525\" height=\"363\" title=\"S&amp;P 500\" alt=\"S&amp;P 500\" src=\"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2013\/2013-11-18-spx.png?resize=525%2C363&#038;ssl=1\" \/><\/p>\n<p style=\"text-align:right;font-size:.9em;color:#999999;\">* Target calculation: 1725 + ( 1725 &#8211; 1650 ) = 1800<\/p>\n<p>Bellwether transport stock Fedex exceeded its target of $130*, with rising Twiggs Money Flow indicating strong buying pressure. A bullish sign for the US economy.<\/p>\n<p><img data-recalc-dims=\"1\" loading=\"lazy\" decoding=\"async\" class=\"aligncenter\" width=\"525\" height=\"363\" title=\"Fedex\" alt=\"Fedex\" src=\"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2013\/2013-11-18-fdx.png?resize=525%2C363&#038;ssl=1\" \/><\/p>\n<p style=\"text-align:right;font-size:.9em;color:#999999;\">* Target calculation: 100 + ( 100 &#8211; 70 ) = 130<\/p>\n<p>CBOE Volatility Index (VIX) below 15 continues to indicate low market risk.<\/p>\n<p><img data-recalc-dims=\"1\" loading=\"lazy\" decoding=\"async\" class=\"aligncenter\" width=\"525\" height=\"363\" title=\"VIX Index\" alt=\"VIX Index\" src=\"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2013\/2013-11-18-vix.png?resize=525%2C363&#038;ssl=1\" \/><\/p>\n<p>The Nasdaq 100 continues its accelerating up-trend, breaking resistance at 3400 after a brief consolidation. Rising Twiggs Money Flow, with troughs above the zero line, indicates strong buying pressure. Target for the advance is 3550*. Accelerating trends, or blow-offs, enjoy rapid gains but inevitably end with a sharp fall.<\/p>\n<p><img data-recalc-dims=\"1\" loading=\"lazy\" decoding=\"async\" class=\"aligncenter\" width=\"525\" height=\"363\" title=\"Nasdaq 100\" alt=\"Nasdaq 100\" src=\"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2013\/2013-11-18-ndx.png?resize=525%2C363&#038;ssl=1\" \/><\/p>\n<p style=\"text-align:right;font-size:.9em;color:#999999;\">* Target calculation: 3400 + ( 3400 &#8211; 3250 ) = 3550<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The S&amp;P 500 is advancing strongly but expect some resistance at the target of 1800*. Penetration of the descending trendline on 13-week Twiggs Money Flow suggests that selling pressure is easing. Reversal below 1750 is unlikely at present, but would warn of a correction to at least the secondary trendline at 1700. Short corrections are &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/thepatientinvestor.com\/index.php\/2013\/11\/18\/sp-500-and-nasdaq-bouyant\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;S&#038;P 500 and Nasdaq bouyant&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_mo_disable_npp":"","_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[57,34],"tags":[64,1362,2401,3010],"class_list":["post-8749","post","type-post","status-publish","format-standard","hentry","category-stock-markets","category-us-canada-countries-regions","tag-vix","tag-fedex","tag-nasdaq-100","tag-sp-500"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>S&amp;P 500 and Nasdaq bouyant - the patient investor<\/title>\n<meta name=\"robots\" content=\"noindex, follow\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"S&amp;P 500 and Nasdaq bouyant - the patient investor\" \/>\n<meta property=\"og:description\" content=\"The S&amp;P 500 is advancing strongly but expect some resistance at the target of 1800*. Penetration of the descending trendline on 13-week Twiggs Money Flow suggests that selling pressure is easing. Reversal below 1750 is unlikely at present, but would warn of a correction to at least the secondary trendline at 1700. Short corrections are &hellip; Continue reading &quot;S&#038;P 500 and Nasdaq bouyant&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/thepatientinvestor.com\/index.php\/2013\/11\/18\/sp-500-and-nasdaq-bouyant\/\" \/>\n<meta property=\"og:site_name\" content=\"the patient investor\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61572934660810\" \/>\n<meta property=\"article:published_time\" content=\"2013-11-18T05:58:05+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/static.incrediblecharts.com\/images\/2013\/2013-11-18-spx.png\" \/>\n<meta name=\"author\" content=\"ColinTwiggs\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"ColinTwiggs\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2013\\\/11\\\/18\\\/sp-500-and-nasdaq-bouyant\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2013\\\/11\\\/18\\\/sp-500-and-nasdaq-bouyant\\\/\"},\"author\":{\"name\":\"ColinTwiggs\",\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/#\\\/schema\\\/person\\\/cb072791ac83e8bae585007c133d54a5\"},\"headline\":\"S&#038;P 500 and Nasdaq bouyant\",\"datePublished\":\"2013-11-18T05:58:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2013\\\/11\\\/18\\\/sp-500-and-nasdaq-bouyant\\\/\"},\"wordCount\":153,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2013\\\/11\\\/18\\\/sp-500-and-nasdaq-bouyant\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.incrediblecharts.com\\\/images\\\/2013\\\/2013-11-18-spx.png\",\"keywords\":[\"$VIX\",\"Fedex\",\"NASDAQ 100\",\"S&amp;P 500\"],\"articleSection\":[\"Stock Markets\",\"US &amp; Canada\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2013\\\/11\\\/18\\\/sp-500-and-nasdaq-bouyant\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2013\\\/11\\\/18\\\/sp-500-and-nasdaq-bouyant\\\/\",\"url\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2013\\\/11\\\/18\\\/sp-500-and-nasdaq-bouyant\\\/\",\"name\":\"S&P 500 and Nasdaq bouyant - the patient investor\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2013\\\/11\\\/18\\\/sp-500-and-nasdaq-bouyant\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2013\\\/11\\\/18\\\/sp-500-and-nasdaq-bouyant\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.incrediblecharts.com\\\/images\\\/2013\\\/2013-11-18-spx.png\",\"datePublished\":\"2013-11-18T05:58:05+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2013\\\/11\\\/18\\\/sp-500-and-nasdaq-bouyant\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2013\\\/11\\\/18\\\/sp-500-and-nasdaq-bouyant\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2013\\\/11\\\/18\\\/sp-500-and-nasdaq-bouyant\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.incrediblecharts.com\\\/images\\\/2013\\\/2013-11-18-spx.png\",\"contentUrl\":\"https:\\\/\\\/www.incrediblecharts.com\\\/images\\\/2013\\\/2013-11-18-spx.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2013\\\/11\\\/18\\\/sp-500-and-nasdaq-bouyant\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/thepatientinvestor.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"S&#038;P 500 and Nasdaq bouyant\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/#website\",\"url\":\"https:\\\/\\\/thepatientinvestor.com\\\/\",\"name\":\"The Patient Investor\",\"description\":\"Smart. Strategic. Unfiltered. \",\"publisher\":{\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/thepatientinvestor.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/#organization\",\"name\":\"The Patient Investor Pty Ltd\",\"url\":\"https:\\\/\\\/thepatientinvestor.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/i0.wp.com\\\/thepatientinvestor.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1\",\"contentUrl\":\"https:\\\/\\\/i0.wp.com\\\/thepatientinvestor.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1\",\"width\":250,\"height\":250,\"caption\":\"The Patient Investor Pty Ltd\"},\"image\":{\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61572934660810\",\"https:\\\/\\\/www.instagram.com\\\/colin_thepatientinvestor\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/#\\\/schema\\\/person\\\/cb072791ac83e8bae585007c133d54a5\",\"name\":\"ColinTwiggs\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/876c4d990bb2af282291d5f3ff81533c6deccc0c607846086647ca3272fac0ca?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/876c4d990bb2af282291d5f3ff81533c6deccc0c607846086647ca3272fac0ca?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/876c4d990bb2af282291d5f3ff81533c6deccc0c607846086647ca3272fac0ca?s=96&d=mm&r=g\",\"caption\":\"ColinTwiggs\"},\"url\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/author\\\/colin58s\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"S&P 500 and Nasdaq bouyant - the patient investor","robots":{"index":"noindex","follow":"follow"},"og_locale":"en_US","og_type":"article","og_title":"S&P 500 and Nasdaq bouyant - the patient investor","og_description":"The S&amp;P 500 is advancing strongly but expect some resistance at the target of 1800*. Penetration of the descending trendline on 13-week Twiggs Money Flow suggests that selling pressure is easing. Reversal below 1750 is unlikely at present, but would warn of a correction to at least the secondary trendline at 1700. Short corrections are &hellip; Continue reading \"S&#038;P 500 and Nasdaq bouyant\"","og_url":"https:\/\/thepatientinvestor.com\/index.php\/2013\/11\/18\/sp-500-and-nasdaq-bouyant\/","og_site_name":"the patient investor","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61572934660810","article_published_time":"2013-11-18T05:58:05+00:00","og_image":[{"url":"http:\/\/static.incrediblecharts.com\/images\/2013\/2013-11-18-spx.png","type":"","width":"","height":""}],"author":"ColinTwiggs","twitter_card":"summary_large_image","twitter_misc":{"Written by":"ColinTwiggs","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/thepatientinvestor.com\/index.php\/2013\/11\/18\/sp-500-and-nasdaq-bouyant\/#article","isPartOf":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2013\/11\/18\/sp-500-and-nasdaq-bouyant\/"},"author":{"name":"ColinTwiggs","@id":"https:\/\/thepatientinvestor.com\/#\/schema\/person\/cb072791ac83e8bae585007c133d54a5"},"headline":"S&#038;P 500 and Nasdaq bouyant","datePublished":"2013-11-18T05:58:05+00:00","mainEntityOfPage":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2013\/11\/18\/sp-500-and-nasdaq-bouyant\/"},"wordCount":153,"commentCount":0,"publisher":{"@id":"https:\/\/thepatientinvestor.com\/#organization"},"image":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2013\/11\/18\/sp-500-and-nasdaq-bouyant\/#primaryimage"},"thumbnailUrl":"https:\/\/www.incrediblecharts.com\/images\/2013\/2013-11-18-spx.png","keywords":["$VIX","Fedex","NASDAQ 100","S&amp;P 500"],"articleSection":["Stock Markets","US &amp; Canada"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/thepatientinvestor.com\/index.php\/2013\/11\/18\/sp-500-and-nasdaq-bouyant\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/thepatientinvestor.com\/index.php\/2013\/11\/18\/sp-500-and-nasdaq-bouyant\/","url":"https:\/\/thepatientinvestor.com\/index.php\/2013\/11\/18\/sp-500-and-nasdaq-bouyant\/","name":"S&P 500 and Nasdaq bouyant - the patient investor","isPartOf":{"@id":"https:\/\/thepatientinvestor.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2013\/11\/18\/sp-500-and-nasdaq-bouyant\/#primaryimage"},"image":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2013\/11\/18\/sp-500-and-nasdaq-bouyant\/#primaryimage"},"thumbnailUrl":"https:\/\/www.incrediblecharts.com\/images\/2013\/2013-11-18-spx.png","datePublished":"2013-11-18T05:58:05+00:00","breadcrumb":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2013\/11\/18\/sp-500-and-nasdaq-bouyant\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/thepatientinvestor.com\/index.php\/2013\/11\/18\/sp-500-and-nasdaq-bouyant\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/thepatientinvestor.com\/index.php\/2013\/11\/18\/sp-500-and-nasdaq-bouyant\/#primaryimage","url":"https:\/\/www.incrediblecharts.com\/images\/2013\/2013-11-18-spx.png","contentUrl":"https:\/\/www.incrediblecharts.com\/images\/2013\/2013-11-18-spx.png"},{"@type":"BreadcrumbList","@id":"https:\/\/thepatientinvestor.com\/index.php\/2013\/11\/18\/sp-500-and-nasdaq-bouyant\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/thepatientinvestor.com\/"},{"@type":"ListItem","position":2,"name":"S&#038;P 500 and Nasdaq bouyant"}]},{"@type":"WebSite","@id":"https:\/\/thepatientinvestor.com\/#website","url":"https:\/\/thepatientinvestor.com\/","name":"The Patient Investor","description":"Smart. Strategic. Unfiltered. ","publisher":{"@id":"https:\/\/thepatientinvestor.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/thepatientinvestor.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/thepatientinvestor.com\/#organization","name":"The Patient Investor Pty Ltd","url":"https:\/\/thepatientinvestor.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/thepatientinvestor.com\/#\/schema\/logo\/image\/","url":"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2026\/03\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1","contentUrl":"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2026\/03\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1","width":250,"height":250,"caption":"The Patient Investor Pty Ltd"},"image":{"@id":"https:\/\/thepatientinvestor.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61572934660810","https:\/\/www.instagram.com\/colin_thepatientinvestor"]},{"@type":"Person","@id":"https:\/\/thepatientinvestor.com\/#\/schema\/person\/cb072791ac83e8bae585007c133d54a5","name":"ColinTwiggs","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/876c4d990bb2af282291d5f3ff81533c6deccc0c607846086647ca3272fac0ca?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/876c4d990bb2af282291d5f3ff81533c6deccc0c607846086647ca3272fac0ca?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/876c4d990bb2af282291d5f3ff81533c6deccc0c607846086647ca3272fac0ca?s=96&d=mm&r=g","caption":"ColinTwiggs"},"url":"https:\/\/thepatientinvestor.com\/index.php\/author\/colin58s\/"}]}},"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p9tQ4n-2h7","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":8813,"url":"https:\/\/thepatientinvestor.com\/index.php\/2013\/12\/03\/bullish-outlook-despite-retracement\/","url_meta":{"origin":8749,"position":0},"title":"Bullish outlook despite retracement","author":"ColinTwiggs","date":"December 3, 2013","format":false,"excerpt":"Dow Jones Industrial Average retraced to test short-term support at 16000. Breach would suggest a correction to test the rising trendline at 15500. Mild bearish divergence on 13-week Twiggs Money Flow warns of medium-term selling pressure. Target for the advance is 16600* and respect of support at 15500 would suggest\u2026","rel":"","context":"In &quot;Stock Markets&quot;","block_context":{"text":"Stock Markets","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/stock-markets\/"},"img":{"alt_text":"Dow Jones Industrial Average","src":"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2013\/2013-12-03-dow.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2013\/2013-12-03-dow.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2013\/2013-12-03-dow.png?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":8789,"url":"https:\/\/thepatientinvestor.com\/index.php\/2013\/11\/25\/dow-leads-us-climb\/","url_meta":{"origin":8749,"position":1},"title":"Dow leads US climb","author":"ColinTwiggs","date":"November 25, 2013","format":false,"excerpt":"Dow Jones Industrial Average is advancing strongly, with rising 13-week Twiggs Money Flow indicating medium-term buying pressure. Target for the advance is 16600*. Retracement to test the new support level remains likely, however, and respect would confirm the advance. Reversal below 15700 is unlikely, but would test the secondary rising\u2026","rel":"","context":"In &quot;Stock Markets&quot;","block_context":{"text":"Stock Markets","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/stock-markets\/"},"img":{"alt_text":"Dow Jones Industrial Average","src":"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2013\/2013-11-25-dow.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2013\/2013-11-25-dow.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2013\/2013-11-25-dow.png?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":11147,"url":"https:\/\/thepatientinvestor.com\/index.php\/2014\/10\/21\/another-bear-trap\/","url_meta":{"origin":8749,"position":2},"title":"Another bear trap?","author":"ColinTwiggs","date":"October 21, 2014","format":false,"excerpt":"Bellwether transport stock Fedex found support at $154, the long tail and rising 13-week Twiggs Money Flow indicating buying pressure. Expect a test of $165. Reversal below $150 is unlikely, but would warn of a test of primary support at $130. Continuation of the primary up-trend signals improvement for the\u2026","rel":"","context":"In &quot;Stock Markets&quot;","block_context":{"text":"Stock Markets","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/stock-markets\/"},"img":{"alt_text":"Fedex","src":"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2014\/2014-10-21-fdx.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2014\/2014-10-21-fdx.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2014\/2014-10-21-fdx.png?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":4011,"url":"https:\/\/thepatientinvestor.com\/index.php\/2012\/04\/01\/bearish-divergence-for-us-indices\/","url_meta":{"origin":8749,"position":3},"title":"Bearish divergence for US indices","author":"Colin Twiggs","date":"April 1, 2012","format":false,"excerpt":"Bearish divergence on 21-day Twiggs Money Flow warns of medium-term selling pressure on the S&P 500 index. Expect a correction to test support at 1350\/1370 unless we see 21-day Twiggs Money Flow recovering above 30%. * Target calculation: 1300 + (1300 - 1150) = 1450 The Nasdaq 100 index encountered\u2026","rel":"","context":"In &quot;Stock Markets&quot;","block_context":{"text":"Stock Markets","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/stock-markets\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":8682,"url":"https:\/\/thepatientinvestor.com\/index.php\/2013\/10\/27\/us-canada-rising-buying-pressure\/","url_meta":{"origin":8749,"position":4},"title":"US &#038; Canada: Rising buying pressure","author":"ColinTwiggs","date":"October 27, 2013","format":false,"excerpt":"The S&P 500 short retracement at 1750 is a bullish sign, confirming the advance to 1800*. Rising 21-Day Twiggs Money Flow indicates buying pressure. Reversal below 1730 is most unlikely at present, but would warn of a test of primary support at 1650. * Target calculation: 1730 + ( 1730\u2026","rel":"","context":"In &quot;Stock Markets&quot;","block_context":{"text":"Stock Markets","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/stock-markets\/"},"img":{"alt_text":"S&P 500","src":"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2013\/2013-10-28-spx.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2013\/2013-10-28-spx.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2013\/2013-10-28-spx.png?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":6931,"url":"https:\/\/thepatientinvestor.com\/index.php\/2013\/03\/11\/sp-500-tests-2007-high\/","url_meta":{"origin":8749,"position":5},"title":"S&#038;P 500 tests 2007 high","author":"Colin Twiggs","date":"March 11, 2013","format":false,"excerpt":"Dow Jones Industrial Average has broken through its previous high at 14,000. Long-term (13-week) Twiggs Money Flow oscillating above zero indicates strong buying pressure. Bellwether transport stock Fedex breakout above $100 signals rising economic activity. The S&P 500 is testing its 2007 high at 1550. Rising 13-week Twiggs Money Flow\u2026","rel":"","context":"In &quot;Banks &amp; Interest Rates&quot;","block_context":{"text":"Banks &amp; Interest Rates","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/economy\/the-fed-banks-interest-rates\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]}],"_links":{"self":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/posts\/8749","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/comments?post=8749"}],"version-history":[{"count":0,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/posts\/8749\/revisions"}],"wp:attachment":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/media?parent=8749"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/categories?post=8749"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/tags?post=8749"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}